Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy.

Lepikhova T, Karhemo PR, Louhimo R, Yadav B, Murumägi A, Kulesskiy E, Kivento M, Sihto H, Grénman R, Syrjänen SM, Kallioniemi O, Aittokallio T, Wennerberg K, Joensuu H, Monni O.

Mol Cancer Ther. 2018 Sep;17(9):2060-2071. doi: 10.1158/1535-7163.MCT-17-0733. Epub 2018 Jul 3.

PMID:
29970484
2.

Human papillomavirus 16 E2-, E6- and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohort.

Koskimaa HM, Paaso AE, Welters MJ, Grénman SE, Syrjänen KJ, van der Burg SH, Syrjänen SM.

J Transl Med. 2014 Feb 13;12:44. doi: 10.1186/1479-5876-12-44.

3.

High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort.

Rintala MA, Louvanto K, Rantanen V, Grénman SE, Syrjänen KJ, Syrjänen SM.

Scand J Infect Dis. 2012 Feb;44(2):115-25. doi: 10.3109/00365548.2011.619999. Epub 2011 Nov 6.

PMID:
22053923
4.

Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV Study.

Louvanto K, Rintala MA, Syrjänen KJ, Grénman SE, Syrjänen SM.

BMC Infect Dis. 2011 Jun 22;11:179. doi: 10.1186/1471-2334-11-179.

5.

Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa.

Paaso AE, Louvanto K, Syrjänen KJ, Waterboer T, Grénman SE, Pawlita M, Syrjänen SM.

J Gen Virol. 2011 Sep;92(Pt 9):2034-46. doi: 10.1099/vir.0.032011-0. Epub 2011 Jun 1.

PMID:
21632564
6.

Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.

Louvanto K, Syrjänen KJ, Rintala MA, Grénman SE, Syrjänen SM.

Acta Obstet Gynecol Scand. 2011 Feb;90(2):167-73. doi: 10.1111/j.1600-0412.2010.01029.x. Epub 2010 Dec 7.

PMID:
21241262
7.

Prepolymerized vs. in situ-polymerized fiber-reinforced composite implants--a pilot study.

Ballo AM, Närhi TO, Akca EA, Ozen T, Syrjänen SM, Lassila LV, Vallittu PK.

J Dent Res. 2011 Feb;90(2):263-7. doi: 10.1177/0022034510384737. Epub 2010 Nov 5.

PMID:
21057035
8.

Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study.

Louvanto K, Rintala MA, Syrjänen KJ, Grénman SE, Syrjänen SM.

J Infect Dis. 2010 Aug 15;202(3):436-44. doi: 10.1086/653826.

PMID:
20557239
9.

Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study.

Louvanto K, Syrjänen KJ, Rintala MA, Grénman SE, Syrjänen SM.

J Clin Microbiol. 2010 Aug;48(8):2665-71. doi: 10.1128/JCM.00783-10. Epub 2010 Jun 16.

10.

Effect of second pregnancy on maternal carriage and outcome of high-risk human papillomavirus (HPV). Experience from the prospective finnish family HPV study.

Sarkola ME, Grénman SE, Rintala MA, Syrjanen KJ, Syrjanen SM.

Gynecol Obstet Invest. 2009;67(3):208-16. doi: 10.1159/000209204. Epub 2009 Mar 16.

PMID:
19287178
11.

Human papillomavirus in the placenta and umbilical cord blood.

Sarkola ME, Grénman SE, Rintala MA, Syrjänen KJ, Syrjänen SM.

Acta Obstet Gynecol Scand. 2008;87(11):1181-8. doi: 10.1080/00016340802468308.

PMID:
18972230
12.

The performance of the HPV16 real-time PCR integration assay.

Ruutu MP, Kulmala SM, Peitsaro P, Syrjänen SM.

Clin Biochem. 2008 Apr;41(6):423-8. doi: 10.1016/j.clinbiochem.2007.12.014. Epub 2008 Jan 3.

PMID:
18206116
13.

Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.

Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB, Syrjänen SM; NIS Study Group.

J Med Virol. 2007 Jun;79(6):771-81.

PMID:
17457909
14.

Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study.

Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB, Johansson BC, Syrjänen SM; New Independent States of the former Soviet Union Cohort Study Group.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):17-22.

15.

Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen SM, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Int J Gynecol Pathol. 2006 Oct;25(4):383-92.

PMID:
16990717
16.

Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.

Kulmala SM, Syrjänen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi P, Syrjänen KJ, Johansson BC.

J Clin Pathol. 2006 May;59(5):513-7. Epub 2006 Feb 16.

17.

High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study.

Rintala MA, Grénman SE, Järvenkylä ME, Syrjänen KJ, Syrjänen SM.

Clin Infect Dis. 2005 Dec 15;41(12):1728-33. Epub 2005 Nov 7.

PMID:
16288396
18.

Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland.

Rintala MA, Grénman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO, Syrjänen SM.

J Clin Microbiol. 2005 Jan;43(1):376-81.

19.

Detection of high-risk HPV DNA in semen and its association with the quality of semen.

Rintala MA, Grénman SE, Pöllänen PP, Suominen JJ, Syrjänen SM.

Int J STD AIDS. 2004 Nov;15(11):740-3.

PMID:
15537460
20.

Human papillomavirus DNA is found in the vas deferens.

Rintala MA, Pöllänen PP, Nikkanen VP, Grénman SE, Syrjänen SM.

J Infect Dis. 2002 Jun 1;185(11):1664-7. Epub 2002 May 17.

PMID:
12023775
21.

Systemic and local effects of long-term exposure to alkaline drinking water in rats.

Merne ME, Syrjänen KJ, Syrjänen SM.

Int J Exp Pathol. 2001 Aug;82(4):213-9.

22.

Dental unit water systems harbor large numbers of microorganisms.

Merne ME, Puranen MH, Syrjänen SM, Hyvönen PM.

Infect Control Hosp Epidemiol. 2000 May;21(5):301-2. No abstract available.

PMID:
10823555
23.

New concepts on the role of human papillomavirus in cell cycle regulation.

Syrjänen SM, Syrjänen KJ.

Ann Med. 1999 Jun;31(3):175-87. Review.

PMID:
10442672
24.

Human papillomavirus (HPV) typing as an adjunct to cervical cancer screening.

Syrjänen KJ, Syrjänen SM.

Cytopathology. 1999 Feb;10(1):8-15. Review. No abstract available.

PMID:
10068882
25.

Snuff use and smoking among senior high school students: effects of a snuff sales ban.

Merne ME, Tiekso JT, Syrjänen SM.

Oral Dis. 1998 Sep;4(3):207-12.

PMID:
9972172
26.

Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia.

Hietala KA, Kosma VM, Syrjänen KJ, Syrjänen SM, Kellokoski JK.

J Pathol. 1997 Nov;183(3):305-10.

PMID:
9422986
27.

Expression and mutations of p53 in salivary gland tumours.

Kärjä VJ, Syrjänen KJ, Kurvinen AK, Syrjänen SM.

J Oral Pathol Med. 1997 May;26(5):217-23.

PMID:
9178173
28.

Exposure of an infant to cervical human papillomavirus infection of the mother is common.

Puranen MH, Yliskoski MH, Saarikoski SV, Syrjänen KJ, Syrjänen SM.

Am J Obstet Gynecol. 1997 May;176(5):1039-45.

PMID:
9166165
29.

Detection of Epstein-Barr virus in salivary gland specimens from Sjögren's syndrome patients.

Merne ME, Syrjänen SM.

Laryngoscope. 1996 Dec;106(12 Pt 1):1534-9.

PMID:
8948618
30.

Immunocompetent cells in benign and malignant salivary gland tumors.

Kärjä VJ, Syrjänen KJ, Syrjänen SM.

Gen Diagn Pathol. 1996 Oct;142(2):75-81.

PMID:
8950571
31.
32.

Human papillomavirus in laryngeal papillomas and in adjacent normal epithelium.

Rihkanen H, Aaltonen LM, Syrjänen SM.

Clin Otolaryngol Allied Sci. 1993 Dec;18(6):470-4.

PMID:
8877222
33.

Lesions of the oral mucosa in lymphoma patients receiving cytostatic drugs.

Laine PO, Lindqvist JC, Pyrhönen SO, Teerenhovi LM, Syrjänen SM, Meurman JH.

Eur J Cancer B Oral Oncol. 1993 Oct;29B(4):291-4.

PMID:
11706423
34.

Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.

Tervahauta AI, Syrjänen SM, Väyrynen M, Saastamoinen J, Syrjänen KJ.

Anticancer Res. 1993 Jul-Aug;13(4):1107-11.

PMID:
8394670
35.

Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections.

Kellokoski JK, Syrjänen SM, Chang F, Yliskoski M, Syrjänen KJ.

J Oral Pathol Med. 1992 Nov;21(10):459-64.

PMID:
1334147
36.

Immunohistochemistry, in situ hybridization and polymerase chain reaction (PCR) in detecting c-myc expression in human malignancies.

Tervahauta AI, Syrjänen SM, Kallio PJ, Syrjänen KJ.

Anticancer Res. 1992 May-Jun;12(3):1005-11.

PMID:
1622111
37.

A papillomavirus related to HPV type 13 in oral focal epithelial hyperplasia in the pygmy chimpanzee.

Van Ranst M, Fuse A, Sobis H, De Meurichy W, Syrjänen SM, Billiau A, Opdenakker G.

J Oral Pathol Med. 1991 Aug;20(7):325-31.

PMID:
1654423
38.

Positive identification of victims by comparison of ante-mortem and post-mortem dental radiographs.

Sainio P, Syrjänen SM, Komakow S.

J Forensic Odontostomatol. 1990 Jun;8(1):11-6.

PMID:
2098379
40.

Free amino acid levels in oral fluids of normal subjects and patients with periodontal disease.

Syrjänen SM, Alakuijala L, Alakuijala P, Markkanen SO, Markkanen H.

Arch Oral Biol. 1990;35(3):189-93.

PMID:
2190545
41.

Forensic dentistry--recent development towards an independent discipline in modern dentistry.

Syrjänen SM, Sainio P.

Proc Finn Dent Soc. 1990;86(3-4):157-70. Review.

PMID:
2094849
42.

Gingival fluid, beta 2-microglobulin and protein levels as indicators of periodontal disease.

Syrjänen SM, Alakuijala P, Markkanen SO, Markkanen H.

Scand J Dent Res. 1989 Dec;97(6):500-4.

PMID:
2694328
43.

Anal condylomas in men. 1. Histopathological and virological assessment.

Syrjänen SM, von Krogh G, Syrjänen KJ.

Genitourin Med. 1989 Aug;65(4):216-24.

44.

Assessment of labial salivary gland changes in patients with rheumatoid arthritis by subjective and quantitative methods.

Markkanen SO, Syrjänen SM, Lappalainen R, Markkanen H.

Appl Pathol. 1989;7(4):233-40.

PMID:
2803785
45.

Recombinant DNA techniques. Basic concepts and practical applications in oral biology.

Syrjänen SM.

Proc Finn Dent Soc. 1989;85(2):81-93. Review.

PMID:
2664774
46.

Madelung's disease (benign symmetric lipomatosis).

Plotnicov NA, Babayev TA, Lamberg MA, Altonen M, Syrjanen SM.

Oral Surg Oral Med Oral Pathol. 1988 Aug;66(2):171-5.

PMID:
3174050
47.
49.

Cervical smears in assessment of the natural history of human papillomavirus infections in prospectively followed women.

Syrjänen KJ, Mäntyjärvi R, Väyrynen M, Yliskoski M, Syrjänen SM, Saarikoski S, Nurmi T, Parkkinen S, Castrén O.

Acta Cytol. 1987 Nov-Dec;31(6):855-65.

PMID:
2827414
50.

Supplemental Content

Loading ...
Support Center